Back to search results

TBI-RECOVER for Traumatic Brain Injury and Substance Use Disorder

This study is testing a program called TBI-RECOVER to help people with traumatic brain injury (TBI) and substance use disorder (SUD) stay in treatment. TBI-RECOVER includes screening for brain injury and cognitive (thinking) challenges, and suggestions for how to adjust treatment. We want to see if TBI-RECOVER helps people stay in treatment longer and improves their symptoms. You can join if you are an English-speaking adult diagnosed with a substance use disorder and receiving outpatient therapy at a participating clinic. The study will measure how long people stay in treatment and their BASIS-24 scores (a measure of symptoms) after one year. The current status of this study is unclear, and it plans to enroll 900 participants.

Study design
This is an interventional study comparing the TBI-RECOVER program to a control group receiving general information. It aims to enroll 900 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year to measure treatment retention and BASIS-24 scores.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07215221

Implementation of TBI-RECOVER in Substance Use Treatment

Recruiting
NAAges 18+InterventionalTreatment
Ohio State University
~900 participants
Updated 2026-07-07 on ClinicalTrials.gov
What's tested:TBI-RECOVERControl

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Treatment retention
Measured over 1 year
+1 more outcome measured

Conditions

Traumatic Brain Injury
Substance Use Disorder (SUD)

Explore related trials

Cognitive DysfunctionSubstance use disorderTraumatic Encephalopathy

NCT07215221

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • OSU Hospital System

    Columbus, Ohiostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Kathryn Hyzak, PhD
[email protected]
3802836683
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English-speaking; diagnosed with a substance use disorder; assigned to an outpatient provider for psychotherapy at the treatment clinic participating in the study.

Exclusion

None

What this trial measures

  • Treatment retention1 year

    The proportion of treatment sessions attended over one year.

  • BASIS-24 scores1 year

    The Behavior and Symptom Identification Scale (BASIS-24) measures six domains: (1) substance use, (2) impulsive/addictive behaviors, (3) relationships with self and others, (4) depression/anxiety, (5) daily living/role functioning, and (6) psychosis. Each item is rated on a 5-point Likert scale, where 0 = lowest symptom severity and 4 = highest symptom severity. Subscales and the overall score are summed and then divided by the number of non-missing items for a total score. There are no clinical cut-offs.